Healthcare - Biotechnology - NASDAQ - US
$ 0.5315
-8.41 %
$ 31.4 M
Market Cap
-0.71
P/E
BALANCE SHEET
89.1 M
ASSETS
34.3 M
LIABILITIES
54.8 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Elevation Oncology, Inc.
| Current Assets | 88 M |
| Cash & Short-Term Investments | 83.1 M |
| Receivables | 0 |
| Other Current Assets | 4.86 M |
| Non-Current Assets | 1.13 M |
| Long-Term Investments | 0 |
| PP&E | 59 K |
| Other Non-Current Assets | 1.07 M |
| Current Liabilities | 4.14 M |
| Accounts Payable | 507 K |
| Short-Term Debt | 0 |
| Other Current Liabilities | 3.64 M |
| Non-Current Liabilities | 30.1 M |
| Long-Term Debt | 30.1 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 49.3 | 45.9 | 146.3 | 79.4 | 1.7 |
| Short Term Investments | 33.9 | 44.4 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 4.9 | 2.7 | 6.3 | 1.4 | 0.2 |
| Total Current Assets | 88.0 | 93.0 | 149.4 | 80.8 | 1.9 |
| PP&E | 59 K | 98 K | 38 K | 56 K | 0 |
| Intangible Assets | 59 | 98 | 38 | 56 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 1.1 | 1.1 | 32 K | 64.9 K | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 89.1 | 94.2 | 149.5 | 80.9 | 1.9 |
| LIABILITIES | |||||
| Accounts Payable | 0.5 | 6.4 | 5.6 | 5.7 | 0.5 |
| Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.6 | 9.3 | 3.1 | 1.1 | 0.1 |
| Total Current Liabilities | 4.1 | 15.7 | 8.8 | 6.8 | 0.6 |
| Long Term Debt | 30.1 | 29.4 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 2 K | 8 K | 97.2 | 0 |
| Total Liabilities | 34.3 | 45.1 | 8.8 | 104.0 | 7.8 |
| EQUITY | |||||
| Common Stock | 4 K | 2 K | 2 K | 0 | 0 |
| Retained Earnings | (196.0) | (150.3) | (55.2) | (23.1) | (5.9) |
| Other Accumulative Comprehensive Income/Loss | 9 K | (0.2) | (149.5) | 0 | 0 |
| Total Equity | 54.8 | 49.0 | 140.7 | (23.1) | (5.9) |
| Total Liabilities and Equity | 89.1 | 94.2 | 149.5 | 80.9 | 1.9 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 34.1 | 23.3 | 23.2 | 23.8 | 23.8 |